# Inova Health System

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/inova-health-system/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74.2 |
| Citations | 333,911 |
| City | Falls Church |
| Country | US |
| Description | Inova Health System is a research organisation in Falls Church, US. OpenAlex records 3,025 works and 333,911 citations for it. 986 researchers list it as their most recent affiliation. |
| Homepage | http://www.inova.org/ |
| OpenAlex ID | https://openalex.org/I116530498 |
| Region | Virginia |
| Researchers | 986 |
| ROR ID | https://ror.org/04mrb6c22 |
| Type | healthcare |
| Works | 3,025 |

## University papers

Showing 12 of 33.

- [2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of-2/)
- [Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention](https://scholariq.org/papers/global-burden-of-nafld-and-nash-trends-predictions-risk-factors-and-prevention/)
- [2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of/)
- [MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease](https://scholariq.org/papers/mafld-a-consensus-driven-proposed-nomenclature-for-metabolic-associated-fatty/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease/)
- [2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)](https://scholariq.org/papers/2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the-2/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-3/)
- [Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries](https://scholariq.org/papers/maternal-morbidity-associated-with-multiple-repeat-cesarean-deliveries/)
- [Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis](https://scholariq.org/papers/global-perspectives-on-nonalcoholic-fatty-liver-disease-and-nonalcoholic/)
- [A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis](https://scholariq.org/papers/a-phase-3-randomized-controlled-trial-of-resmetirom-in-nash-with-liver-fibrosis/)
- [Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate](https://scholariq.org/papers/prevention-of-recurrent-preterm-delivery-by-17-alpha-hydroxyprogesterone/)
- [Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery](https://scholariq.org/papers/maternal-and-perinatal-outcomes-associated-with-a-trial-of-labor-after-prior/)

## University top topics

Showing 8 of 25.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Diet, Metabolism, and Disease](https://scholariq.org/topics/diet-metabolism-and-disease/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.